Growth Metrics

Neuronetics (STIM) Current Deferred Revenue (2017 - 2025)

Neuronetics (STIM) has disclosed Current Deferred Revenue for 9 consecutive years, with $753000.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 22.69% to $753000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $753000.0 through Dec 2025, down 22.69% year-over-year, with the annual reading at $753000.0 for FY2025, 22.69% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $753000.0 at Neuronetics, roughly flat from $754000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $2.5 million in Q4 2021, with the low at $753000.0 in Q4 2025.
  • Average Current Deferred Revenue over 5 years is $1.5 million, with a median of $1.7 million recorded in 2023.
  • The sharpest move saw Current Deferred Revenue rose 23.81% in 2021, then plummeted 51.63% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $2.5 million in 2021, then decreased by 20.83% to $2.0 million in 2022, then decreased by 18.18% to $1.6 million in 2023, then crashed by 39.88% to $974000.0 in 2024, then dropped by 22.69% to $753000.0 in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $753000.0, $754000.0, and $894000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.